PD-L1 regulation revisited: impact on immunotherapeutic strategies
Giulia Lucibello, Baharia Mograbi, G. Milano, Paul Hofman, Patrick Brest
Topics & Concepts
DruggabilityMonoclonal antibodyImmunotherapyImmune systemClinical trialAdverse effectImmune checkpointMedicinePD-L1CancerImmunologyBioinformaticsComputational biologyCancer researchAntibodyBiologyInternal medicineBiochemistryGeneCancer Immunotherapy and BiomarkersImmune Cell Function and InteractionLung Cancer Research Studies